Nagoya City University Psychiatry

sitemap

Clinical Psychopharmacology

Cipriani A, Furukawa TA, Geddes J, Malvini L, Signoretti A, Churchill R, McGuire H, Nakagawa A & Barbui C (in press) Does randomised evidence support a first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis. Journal of Clinical Psychiatry.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2010) Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis. CNS Drugs, 24, 35-53.
Barbui C, Cipriani A, Furukawa TA, Salanti G, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM & Geddes JR (2009) Making the best use of available evidence: the case of new generation atidepressants. A response to: Are all antidepressants equal? Evidence-Based Mental Health, 12, 101-104.
Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2009) Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. Journal of Psychopharmacoogy, 23, 539-550.
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R & Furukawa TA (2009) Milnacipran versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006529.
Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R & Barbui C (2009) Escitalopram versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006532.
Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H & Barbui C (2009) Sertraline versus other antidepressive agents for depression. Cochrane Database of Systematic Reviews, CD006117.
Watanabe N, Churchill R & Furukawa TA (2009) Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database of Systematic Reviews, CD005335.
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M & Barbui C (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746-758. Paper that changed our practices
Fujita A, Azuma H, Kitamura T, Takahasi K, Akechi T & Furukawa TA (2008) Adequacy of continuation and maintenance treatments for major depression in Japan. Journal of Psychopharmacology, 22, 153-156.
Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R & Furukawa TA (2008) Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: Systematic review and meta-analysis. Journal of Clinical Psychiatry, 69, 1404-1415.
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R & Furukawa TA (2008) Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : A systematic review and meta-analysis. CNS Drugs, 22, 587-602.
Barbui C, Furukawa TA & Cipriani A (2008) Effectiveness of paroxetine in the acute phase treatment of adults with major depression: a systematic re-examination of published and unpublished randomised data. Canadian Medical Association Journal, 178, 296-305.
Watanabe N, Hunot V, Omori IM, Churchill R & Furukawa TA (2007) Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatrica Scandinavica, 116, 84-95.
Watanabe N, Churchill R & Furukawa TA (2007) Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: a systematic review. BMC Psychiatry, 7, 18.
Martin JL, Sainz-Pardo M, Furukawa TA, Martin-Sanchez E, Seoane T & Galan C (2007) Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. Journal of Psychopharmacology, 21, 774-782.
Furukawa T, Watanabe N & Churchill R (2007) Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database of Systematic Reviews, CD004364.
Cipriani A, Geddes JR, Furukawa TA & Barbui C (2007) Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Canadian Journal of Psychiatry, 52, 553-562.
Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, Baumann P, Ghalib K, Markowitz JC, Padberg F, Fink M, Furukawa T, Fountoulakis KN, Jensen P, Kanba S & Riecher-Rossler A (2007) Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. International Journal of Neuropsychopharmacology, 10 Suppl 1, S1-207.
Cipriani A, Barbui C, Brambilla P, Furukawa T, Hotopf M & Geddes J (2006) Are all antidepressants really the same? The case of fluoxetine: a systematic review. Journal of Clinical Psychiatry, 67, 850-864.
Geddes JR, Furukawa TA, Cipriani A & Barbui C (2007) Depressive disorder needs an evidence base commensurate with its public health importance. Canadian Journal of Psychiatry, 52, 543-544.
Cipriani A, Geddes JR, Furukawa TA & Barbui C (2007) Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Canadian Journal of Psychiatry, 52, 553-562.
Furukawa TA, Cipriani A, Barbui C & Geddes JR (2007) Long-term treatment of depression with antidepressants: A systematic narrative review. Canadian Journal of Psychiatry, 52, 545-552.
Furukawa TA, Streiner DL, Young LT & Kinoshita Y (2006) Antidepressants plus benzodiazepine for major depression. Cochrane Database of Systematic Reviews.
Furukawa TA, Watanabe N & Churchill R (2006) Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. British Journal of Psychiatry, 188, 305-312. Paper that changed our practices
Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L & Barbui C (2005) Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database of Systematic Reviews, 4, CD004185.
Furukawa TA (2004) Withdrawal of benzodiazepines in elderly long term users does not produce significant adverse effects in the short term. Evidence-Based Mental Health, 7, 46.
Furukawa T, McGuire H & Barbui C (2003) Low dosage tricyclic antidepressants for depression. Cochrane Database of Systematic Reviews, CD003197.
Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E & Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 361, 653-661. Paper that changed our practices
Inada T, Nozaki S, Inagaki A & Furukawa TA (2003) Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan. Human Psychopharmacology, 18, 483-487.
Furukawa TA, McGuire H & Barbui C (2002) Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ, 325, 991-995. Paper that changed our practices
Furukawa TA, Streiner DL & Young LT (2001) Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. Journal of Affective Disorders, 65, 173-177.
Furukawa T, Streiner DL & Young LT (2000) Antidepressant plus benzodiazepine for major depression. Cochrane Database of Systematic Reviews, CD001026.
Furukawa TA, Kitamura T & Takahashi K (2000) Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study. Journal of Affective Disorders, 60, 173-179.